The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online May 14, 2007
doi:10.1084/jem.20062129
The Journal of Experimental Medicine, Vol. 204, No. 6, 1303-1310
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Bopp et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bopp, T.
Right arrow Articles by Schmitt, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bopp, T.
Right arrow Articles by Schmitt, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

 Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression

Tobias Bopp1, Christian Becker2, Matthias Klein1, Stefan Klein-Heßling4, Alois Palmetshofer4, Edgar Serfling4, Valeska Heib1, Marc Becker1, Jan Kubach2, Steffen Schmitt3, Sabine Stoll2, Hansjörg Schild1, Martin S. Staege5, Michael Stassen1, Helmut Jonuleit2, and Edgar Schmitt1

1 Institute for Immunology, 2 Department of Dermatology, and 3 Center for Natural Sciences and Medicine, Johannes Gutenberg University, 55131 Mainz, Germany
4 Department of Molecular Pathology, Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany
5 Klinik und Poliklinik für Kinder- und Jugendmedizin, Martin Luther University, 06097 Halle-Wittenberg, Germany

CORRESPONDENCE Edgar Schmitt: eschmitt{at}mail.uni-mainz.de

Naturally occurring regulatory T cells (T reg cells) are a thymus-derived subset of T cells, which are crucial for the maintenance of peripheral tolerance by controlling potentially autoreactive T cells. However, the underlying molecular mechanisms of this strictly cell contact–dependent process are still elusive. Here we show that naturally occurring T reg cells harbor high levels of cyclic adenosine monophosphate (cAMP). This second messenger is known to be a potent inhibitor of proliferation and interleukin 2 synthesis in T cells. Upon coactivation with naturally occurring T reg cells the cAMP content of responder T cells is also strongly increased. Furthermore, we demonstrate that naturally occurring T reg cells and conventional T cells communicate via cell contact–dependent gap junction formation. The suppressive activity of naturally occurring T reg cells is abolished by a cAMP antagonist as well as by a gap junction inhibitor, which blocks the cell contact–dependent transfer of cAMP to responder T cells. Accordingly, our results suggest that cAMP is crucial for naturally occurring T reg cell–mediated suppression and traverses membranes via gap junctions. Hence, naturally occurring T reg cells unexpectedly may control the immune regulatory network by a well-known mechanism based on the intercellular transport of cAMP via gap junctions.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

cAMP crosses junctions
Hema Bashyam
J. Exp. Med. 2007 204: 1240b. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS